Asignificant change in the occurrence of oesophageal squamous cell carcinomas (sccs) in relation to adenocarcinomas (Acs) has been observed in the norwegian population during the last 20 years (1988)(1989)(1990)(1991)(1992)(1993)(1994)(1995)(1996)(1997)(1998)(1999)(2000)(2001)(2002)(2003)(2004)(2005)(2006)(2007). the Ac incidence has increased from 5-10% to more than 50% nowadays, while the incidence of sccs has decreased. our goal was to evaluate if the change from scc to Ac and the increased effort to control reflux could be reflected in tumour stage, patient demographics and treatment results.
INTRODUCTION
Oesophageal cancer is not a common malignant disease in developed countries, but remains ap roblem cell carcinomas (SCCs) to ACs have not been entirely clarified, but gastro-oesophageal reflux (GERD) and overweight seem to play important roles (2, 3) .
The majority of patients with the classical symptoms of oesophageal cancer harbour advanced disease when the diagnosis is made. If reflux and development of Barrett's oesophagus are important factors in the carcinogenesis of oesophageal ACs, this could have as ignificant influence on diagnosis, treatment and prophylaxis (4) .
The shift from SCCs to ACs has also been suggested to correlate with changes in the general population, which is consistent with the general statistical trends of socio-cultural factors in the industrialised countries. Patients with SCC are often said to be heavy smokers, to have moret han average alcohol consumption and inclined to have general impaired health and social status, while obesity and altered food habits seem to be characteristic for AC (5, 6) .
GERD-induced dysplasia is believed to be the single most important factor in the demonstrated rapid increase of AC of the oesophagus in Norway. Treatment of GERD has thereforebeen taken seriously by the Norwegian health authorities, and considerable resources have been allocated to both medical and surgical treatments of GERD and surveillance programs. If the diagnosis is made, treatment with proton pump inhibitors (PPI) is reimbursed by the health authorities (7) . Endoscopy and regular follow-up with biopsies of Barrett's changes and dysplasia are subject to national guidelines, as well as surgery when drug therapy does not alleviate symptoms or mucosal changes develop further (8) .
The expected effects -reduction in cases of AC (GERD treatment) and relative increase in early cancer detection (surveillance of GERD) -however, have not been reported so far.
Using two decades of patients referred for evaluation of surgical treatment of oesophageal cancer, we investigated if the change from SCC to AC and the increased effort to control reflux could be reflected in tumour stage, patient demographics and treatment results.
MATERIALS AND METHODS
The Norwegian population is close to 4.7 millions. The Norwegian Radium Hospital yearly receives and assesses for treatment approximately one third of the patients with oesophageal cancer in Norway.
PATIENTS
Patients included in this study were diagnosed with oesophageal cancer in the period from January 1988 until December 2007 and referred to The Norwegian Radium Hospital for surgical treatment evaluation. The diagnostic methods werep erformed according to the contemporary available pre-operative staging practices. Eligible patients werec lassified according to the ICD 10 topography codes C15.0-9 (9) . The patients received all or part of their therapy at the Department of Surgical Oncology.
The biopsies werec ollected using afl exible endoscope, fixed in formalin, embedded in paraffin and stained with haematoxylin and eosin. The surgical tissue specimens wereobtained after atotal or partial oesophagectomy.The oesophagectomies were performed through a right-sided thoracotomy and local lymph node dissection with either ag astro-oesophageal anastomosis in the thorax or in the neck. In cases with no suspicion of lymph node metastases above the carina, a transhiatal oesophagectomy was performed from the abdominal cavity and a left supraclavicular incision with removal of lymph nodes from the hiatus to the carina.
Atotal of 347 referred cases weres tudied. Clinical and pathological information, risk factors at the time of diagnosis and therapy of each case wereregistered in adatabase, using the softwarepackage Access for Windows (Microsoft Office Access 2003). Oesophageal carcinomas were histologically classified into three groups following the WHO grading system (10) . Clinical classification was performed by using TNM staging according to the UICC Global Cancer Control (11) .
In order to compare changes in tumour characteristics and treatment results, the 20-year period was divided into two decades (1988-1997 and 1998-2007) .
STATISTICAL ANALYSIS
The data were analysed with the standard statistical software package SPSS for Windows (SPSS 15.0 for Windows, Advanced Statistics, SPSS Inc, Chicago, 2007). Survival curves were calculated with the Kaplan-Meier productlimit method. Potential prognostic factors weret ested for univariate statistical significance with the log rank test. A two-sided "p" value of 0.05 or less was considered statistically significant.
RESULTS

PATIENT AND TUMOUR CHARACTERISTICS
The incidence rate of oesophageal cancer was three times higher for men than for women. More than 55% of patients were older than 65 years, the median age being 66 years (range 31-91). In spite of as mall but steady increase in number of oesophageal cancers, therew eren os ignificant differences in gender and age between the first and second decade in this study ( Table 1) .
Of all the patients with AC (n =189), 28% had Barrett's oesophagus, and 40% suffered from symptomatic GERD. Of the latter, in more than 50% of cases, GERD was associated with Barrett's oesophagus. There were highly significant increases in both symptomatic GERD and Barrett's oesophagus during the last decade (45% and 32% compared to 29% and 15% in the first decade). These changes were almost exclusively reported in patients with AC, whereas both Barrett's and GERD remained extremely uncommon in cases of SCC.
More than two thirds of the patients reported a history of tobacco use, 50% of them being heavy smokers (moret han 20 cigarettes per day). Alcohol consumption concerned almost 70% of patients, of which 17% were heavy drinkers (morethan 3.5drinks per day). Smoking and heavy drinking were regularly associated with SCC.
Dysphagia was the common symptom leading to diagnosis and evaluation of surgical treatment.
Weight loss accompanied the symptoms in the majority of patients, with almost 27% of the patients having lost 10 kg or more. Except for at rend towards reduced weight loss for AC patients in the second period, no significant differences wereseen between the two cancer types or periods.
Significant changes in tumour type during the two periods with arapid increase in ACs and no changes in SCCs wered emonstrated. Poorly differentiated carcinoma was diagnosed in 45% of patients, while only 3% had well differentiated carcinoma (Table 1) .
TREATMENT
The patients received either single modality or multimodal treatment, adapted according to histology, advancement of disease, tumour location and concomitant disease. Tumours in the proximal thirdo f the oesophagus were not operated but treated with irradiation, with or without chemotherapy.S urgical tumour resection was performed on tumours in the distal two thirds of the oesophagus when therewere no clinical signs of local organ infiltrations, positive lymph nodes, distant metastases or serious concomitant diseases. Patients with oesophageal AC were operated more frequently than patients with SCC (63% and 37% respectively). Preoperative irradiation, usually 35 Gy, was chosen by the oncologist in collaboration with the surgeon.
Two subgroups of patients were studied after surgery: operated without neo-adjuvant irradiation (n =86) and those with (n =75) ( Table 3 ). This is obviously not a study designed to evaluate the effect of irradiation, as significantly morep atients with SCC than AC received preoperative irradiation. Among patients with AC receiving irradiation, the tumours were usually more advanced.
An oesophageal resection was performed in 169 (49%) of the 347 patients. Pathological evaluation was crucial for the assessment of the TNM category (Table  3 ). T4 tumours, metastases or severe concomitant disease werec haracteristic for non-operated patients. Surgery alone was used in nearly 70% of operated ACs, compared to only 20% of operated SCCs. Fortysix percent of patients underwent a transhiatal oesophagectomy and 52% a transthoracal resection. Postoperative mortality (within 30 days) was 4%, and in-hospital mortality was 5.9%. Thirty-nine percent of patients presented postoperative complications in the form of pneumonia, cardio-respiratory failure, anastomosis leakage, chylothorax and wound infection (data not shown).
For patients diagnosed with SCC, radiotherapy alone (external irradiation and brachytheraphy) was the most frequent treatment in both periods (48% of cases). Irradiation, combined with surgery, was applied in 29% of patients with SCC. The corresponding values for ACs were2 1% and 18% (data not shown). No patients received preoperative chemo- therapy treatment alone or combined with radiotherapy. One hundred and eighty patients presented with tumours that were evaluated to be unsuited for surgery or the patients had too poor performance status to be considered for radical surgery.T hese patients received astent insertion, external radiation often supplemented by brachytheraphy or best supportive care.
SURVIVAL
The median survival rate for all patients presented in this study,c alculated from the debut of symptoms, was 13.5 months with a5 -year survival rate of 7.6% for the first decade and 17 months with a 5-year survival rate of 10.4% for the second decade (data not shown). The median survival time for operated and non-operatedpatientswas 25 months and 12 months respectively (Fig. 1) . The 5-year survival rate for all operated patients was 13% and for non-operated patients 2% (p <0.01). Asignificant association between survival time and gender, lymph node status and microscopic free resection margins was demonstrated in patients undergoing surgery as seen in Table 4 . Female patients, patients without lymph node metastasisa nd operated radically had, as expected, longer median survival times and higher 5-year survival rates. Histo- No significantly improved survival could be demonstrated from preoperative irradiation either,b ut a trend towards improvement was seen.
Comparing the two decades, no significant difference between the survival rates could be demonstrated (Table 2) .
Looking further into the results of patients operated with microscopic free resection margins (n =141), the median survival time was 26 months for patients with N0M0 disease and 16 months for patients with N1M0 disease ( Table 5 ). The corresponding 5-year survival rates were28% and 4%. No patients with M1 disease survived five years postoperatively. The patients with N0M0 disease performed, as expected, significantly better than patients with N1M0 disease (p <0.01).
The median survival time was 12 months in patients who had affected resection margins (n =2 8), and in spite of postoperative radiotherapy, only one of these patients survived five years (data not shown). Yes  A1 69  123  66  41  30  21  B  065  048  33  29  23  17  No  C1 78  077  21  10 07 04 Norway rose from 0.8 to 1.1 for women and from 3.3 to 3.7 for men (12) .
DISCUSSION
The increase in AC in the lower part of the oesophagus, together with a slight decrease in SCC during the last decade, is in agreement with other reports from developed countries (1, (13) (14) (15) . Lifestyle related changes are likely to play an important part in this scenario. While heavy smoking and drinking of our patients werer elated to the development of SCC, GERD and Barrett's metaplasia strongly correlated with AC. According to the National Bureau of Statistics in Norway, the total number of smokers constantly diminished since 1998, whereas increasingly more Norwegians suffer from obesity (16, 17) . Weight increase has been postulated to enhance gastrooesophageal reflux, which can lead to as equence of changes from Barrett's metaplasia to dysplasia and cancer (2, 3) . Due to the fact that obesity increases diabetes and cardiovascular diseases, considerable effortshave been introduced by the health authorities to counteract the average weight gain, but so far without any measurable success (16).
The reflux-AC sequence is as low process and is influenced by a number of less well understood factors, as only as mall number of patients with reflux will develop AC. But the fact that the majority of patients with AC have symptoms or signs of reflux could be of great importance in the development of a strategy to improve the dismal results of ar apidly increasing number of patients with AC.
In our series, the 5-year survival rate of all operated patients was 13% and patients with N0M0 disease operated with R0 resection was 28%. These numbers are lower than 5-year survival rates of some other studies (18) (19) (20) (21) . However, our study had a limited number of operated patients (169 patients) compared to other large population-based cohorts (18, 19) . Additionally, ACs (mostly in the second decade) and T3 tumours with lymph node metastases and distant metastases (stages III and IV according to the American Joint Committee on Cancer) -factors which may considerably reduce the 5-year survival ratewere dominant in our series (22) .
It has been reported that patients operated with a transthoracal approach show at rend towards better survival compared to the transhiatal technique (19, 23) . Our results support these findings, where a more extended lymphadenectomy, usually performed during the transthoracal technique, tends to result in survival benefit (19) .
The change from SCC to AC did not lead to improved long time survival in our two series of patients. This, however,isnot related to local hospitals treating early cancers and referring only advanced cancers to our hospital, because the data from the National Cancer Registry show no increased number of early cancers or improved survival results during the periods. The expectations that increased awareness, observation and treatment of reflux would lead to referral of moree arly cases of AC weren ot met. Therew erei nf act as ignificantly increased number of patients in the second period with lymph node metastases, organ metastases or locally advanced tumours. The lymph node metastases were mostly found in distal AC (Table 2) , which could be due to lesser use of preoperative irradiation and/or the rapid development of lymph node metastasis in distal ACs of the oesophagus before occurrence of symptoms.
Almost all of our referred patients (noticeably more in the second period) suffered, among other symptoms, from either dysphagia or weight loss, or both. Considering the survival rates, dysphagia and weight loss areobvious late symptoms and thus not likely to be the focus of improvement. Preoperative radiotherapy was used less frequently in the second period, with no neo-adjuvant chemo-radiation regimens.
The recently demonstrated results of aggressive neo-adjuvant therapy and the disappointing small number of early cancers have led us to reconsider this strategy (24) . The Norwegian Radium Hospital will participate in two Scandinavian trials, one being a study for resectable cancer of the oesophagus and gastro-oesophageal junction (NeoRes) and the other being a study on the treatment with Taxotere in combination with Xeloda in patients with metastatic oesophageal cancer or cancer in the cardia region (TaxXel).
The mucosal changes in the form of Barrett's oesophagus, dysplasia and, sometimes, the common symptom GERD, have been proposed as treatment targets to combat AC (19) . While medical treatment has doubled over the last decade, anti-reflux surgery has increased by 10 times over the last two decades, and both continue to increase steadily (25, 26) . Incredibly enough, despite the increase of these treatment alternatives in ap opulation wheret hey are commonly available and almost free of charge, we could not demonstrate any significant improvement, neither in the survival of oesophageal cancer in general or in the subgroup of AC. Despite the recognisable upwards trend in AC occurrence, only a small number of ACs was detected in the early stage. Admittedly,the fact that the four only cases of early AC were referred in the second period could be a result of increased surveillance (regular endoscopy and biopsies) of reflux patients. This very modest improvement in early cases of AC should inspirenot only the introduction of am ores tandardised surveillance regimen, but even morei mportantly,t he search for early molecular tissue markers of malignant development (27) (28) (29) (30) . Oesophageal resection is a major surgical procedure with significant mortality and morbidity. Reliable molecular markers, combined with morphology, could change the future strategy towards local treatment of pre-malignant lesions and neoadjuvant regimens of clinical cancers.
Our experience from the two reported time periods has demonstrated that in spite of considerable efforts to treat symptomatic reflux free of charge (drugs or anti-reflux surgery) and propose surveillance regimens, the increase in AC continues with a disappointing low rate of early cases. Anti-reflux therapy combined with local use of photodynamic therapy (PDT) and mucosal ablation of pre-malignant lesions characterised by acombination of previously and newly developed markers areg oing to be a part of our oesophageal cancer program in the nearest feature.
